Ivor Royston - Concepedia

Author

Ivor Royston

University of California San Diego

Also Known As

I ROYSTON, I Royston, I. ROYSTON, I. Royston, IVOR ROYSTON, Ivor Royston, Royston, Ivor

122

Publications

6.9K

Citations

H-Index

Concepts

All Affiliations

University of California San Diego Sidney Kimmel Cancer Center University of California San Diego Medical Center United States Department of Veterans Affairs University of Colorado Denver

About

Ivor Royston is an author at University of California San Diego specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	36	2.4K
2	Allergy	8	8	1K
3	Health Sciences	5	5	311
4	Public Health	4	4	307
5	Biochemistry	2	2	59

Ivor Royston

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma David G. Maloney, Antonio J Grillo-López, Christine A. White, Blood	1997	1.7K
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. DG Maloney, A.J. Grillo-López, David Bodkin, Journal of Clinical Oncology	1997	636
Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. Ivor Royston, John A. Majda, Stephen M. Baird, The Journal of Immunology T101 AntibodyImmunologyImmunophenotypingCll PatientsAntigen Processing	1980	421
Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy. Habib Fakhrai, Oliver Dorigo, Daniel L. Shawler, Proceedings of the National Academy of Sciences	1996	338
Clinical Importance of Myeloid Antigen Expression in Adult Acute Lymphoblastic Leukemia Robert E. Sobol, Rosemarie Mick, Ivor Royston, New England Journal of Medicine	1987	320
Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody. Robert O. Dillman, Daniel L. Shawler, Jacquelyn B. Dillman, Journal of Clinical Oncology Chronic Lymphocytic LeukemiaImmunologyPathologyImmunophenotypingImmunotherapy	1984	175
Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemia RO Dillman, D.L. SHAWLER, RE Sobol, Blood	1982	168
IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma David G. Maloney, Antonio J Grillo-López, Christine A. White, Blood	1997	156
UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas. Mark C. Glassy, Harold H. Handley, H. Hagiwara, Proceedings of the National Academy of Sciences HistocompatibilityCytogeneticsLymphocyte DevelopmentImmunologyPathology	1983	152
Cell-Mediated Immunity to Epstein–Barr-Virus-Transformed Lymphoblastoid Cells in Acute Infectious Mononucleosis Ivor Royston, John L. Sullivan, Phillip Periman, New England Journal of Medicine Adaptive Immune SystemImmune RegulationImmunologyPathologyImmunophenotyping	1975	122

Page 1